Author Question: If a clinician appears to show the characteristics of being at Stage Three at the beginning of a ... (Read 60 times)

SO00

  • Hero Member
  • *****
  • Posts: 568
If a clinician appears to show the characteristics of being at Stage Three at the
  beginning of a field experience, which of these explanations is more likely?
 
  A. The clinician is dealing with anxiety by pretending to be confident.
  B. The clinician is a graduate of an accelerated program.
  C. The clinician is progressing rapidly because of a tendency to approach
  anxiety.
  D. The clinician's performance is likely to alternate between Stages Two and
  Three.

Question 2

Linus likes everything about his new supervisory position except his own supervisor.
  When Linus asks for advice, Marvin encourages him to figure things out for himself.
  Feeling overwhelmed, Linus turns to his former coworkers for advice.
 
  What critical
  mistake has Marvin made?
  A. failing to help Linus form new supportive bonds with him and other managers
  B. forgetting that Linus needs time to get comfortable with new people
  C. ignoring Linus's need for training in clinical assessment skills
  D. expecting Linus to establish rapport with a wider variety of people



Mollythedog

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

A

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

There are over 65,000 known species of protozoa. About 10,000 species are parasitic.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library